Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,110 | 27,769 | 54,548 | 4,648 | 4,567 |
| Marketable Securities | 24,312 | 15,956 | 19 | 19 | 19 |
| Receivables | 1,252 | 923 | 1,973 | 1,289 | 1,210 |
| Inventories | N/A | N/A | 1,635 | 2,574 | 2,136 |
| Other current assets | 0 | 3,695 | 0 | 0 | 0 |
| TOTAL | $31,430 | $48,956 | $59,952 | $8,651 | $8,050 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 234 | 228 | 138 |
| Investments And Advances | 0 | 0 | 0 | 0 | 76 |
| Intangibles | 19,935 | 21,024 | 659 | 1,332 | 2,833 |
| Other Non-Current Assets | 2,015 | 1,151 | 1,107 | 192 | 196 |
| TOTAL | $21,950 | $22,174 | $1,999 | $1,752 | $3,242 |
| Total Assets | $53,379 | $71,130 | $61,952 | $10,403 | $11,292 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,665 | N/A |
| Accounts payable and accrued liabilities | 2,091 | 2,247 | 2,735 | 3,956 | 2,215 |
| TOTAL | $2,091 | $3,745 | $2,835 | $5,710 | $2,215 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,579 |
| Other Non-Current Liabilities | 0 | 0 | 80 | 49 | 0 |
| TOTAL | $20,903 | $22,044 | $21,021 | $1,852 | $3,407 |
| Total Liabilities | $22,994 | $25,789 | $23,856 | $7,562 | $5,622 |
| Shareholders' Equity | |||||
| Common Shares | 107,036 | 111,331 | 84,562 | 37,339 | 28,183 |
| Retained earnings | -98,716 | -88,569 | -65,146 | -44,862 | -30,733 |
| Other shareholders' equity | 7,765 | 8,189 | 7,847 | 1,988 | 2,097 |
| TOTAL | $30,386 | $45,341 | $38,095 | $2,841 | $5,670 |
| Total Liabilities And Equity | $53,379 | $71,130 | $61,952 | $10,404 | $11,292 |